Frost and Sullivan honors Siemens for Medical Imaging Growth and Technology Excellence

Frost & Sullivan recently presented its 2006 Medical Imaging Growth Award and 2005 Award for Excellence in Technology to Siemens Medical Solutions. Each year the Medical Imaging Growth Award is given to a company that has demonstrated an exceptional growth strategy within its industry. Siemens was chosen this year in recognition of its renewed commitment to pursue innovative growth strategies that forge the way for continued market expansion and sustained industry ascendancy.

Siemens' product portfolio encompasses a line of products and services spanning the entire range of medical imaging modalities and clinical specialties, from computed tomography (CT), magnetic resonance imaging (MRI) and digital radiography (DR) to highly-specialized offerings in mammography, surgical-interventional imaging and oncology care. As an example of Siemens' long-term growth vision, the SOMATOM® Definition is the first dual-source CT system, capable of producing extraordinary images at nearly half the radiation exposure, compared with traditional single-source CT scanners. The MAGNETOM line of MRI systems is flexible enough to meet the diverse needs of both large and small imaging facilities, offering a full range of field strengths, from 0.35 Tesla (.035T) to 3T. In addition, Siemens' entire MRI platform features Siemens’ patented Tim® (Total imaging matrix) coils, providing superior image quality while maintaining a high degree of patient comfort.

The AXIOM series of DR systems includes state-of-the-art amorphous silicon digital detectors, ensuring the highest image quality at the lowest effective radiation dose. Moreover, through Soarian®, Siemens can provide seamless integration and interoperability of its entire imaging portfolio, including Picture Archiving and Communication Systems (PACS), with non-imaging clinical and administrative information systems. Soarian seamlessly integrates medical images into the entire breadth of enterprise healthcare information systems, including clinical, financial and diagnostic data, facilitating a superlative level of automation and efficiency in the management of vast amounts of healthcare data.

Frost & Sullivan's Excellence in Technology Award is given to a company that has pioneered the development and introduction of an innovative technology into the market, and either impacted or has the potential to impact several market sectors. In the field of fusion technology for medical diagnostics, Siemens and the University of Tennessee are recognized for their collaborative effort to create a unique PET/CT (Positron Emission Tomography/Computed Tomography) hybrid that uses LSO HI REZ (Lutetium Oxyorthosilicate high-resolution) technology to bring high-resolution fusion imaging into clinical practice. This solution offers more than 250 percent improvement in volumetric spatial resolution for PET imaging, which permits very small crystal elements to be assembled and efficiently incorporated into the PET/CT scanner design.

"Siemens is proud to be a long-term partner with Frost & Sullivan, and we are honored to receive this recognition from such a prestigious organization in the medical imaging industry," said Tom McCausland, president, Siemens Medical Solutions, USA. "Advancing medical imaging technology with constant attention to customer care is the major factor that differentiates Siemens from its competitors," says Subha B. Basu, research analyst, Medical Imaging Group, Frost & Sullivan. "The culture of giving equal attention to both patient comfort and clinician requirements is evident across all Siemens' products, which helps it maintain its position as a leader in healthcare technology."

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com

Siemens Medical Solutions of Siemens AG (NYSE: SI) with headquarters in Malvern, Pennsylvania, and Erlangen, Germany, is one of the largest suppliers to the healthcare industry in the world. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Employing approximately 33,000 people worldwide and operating in more than 120 countries, Siemens Medical Solutions reported sales of 7.6 billion EUR, orders of 8.6 billion EUR and group profit of 976 million EUR for fiscal 2005. More information can be obtained by visiting http://www.usa.siemens.com/medical-pressroom

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...